Company: PIII
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001140361-25-016302
Chunk: 13

Company: P3 Health Partners Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 13
---
 biographies appear below. In the event that any of Sherif Abdou, M.D., Greg Kazarian or Greg Wasson should become unable to serve, or for good cause will not serve, as a director, it is intended that votes will be cast for a substitute nominee designated by the Board or the Board may elect to reduce its size. The Board has no reason to believe that any of Sherif Abdou, M.D., Greg Kazarian or Greg Wasson will be unable to serve if elected. Each of Sherif Abdou, M.D., Greg Kazarian and Greg Wasson has consented to being named in this proxy statement and to serve if elected. Vote required The proposal regarding the election of directors requires the approval of a plurality of the votes cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Class I Directors. Votes withheld and broker non-votes are not considered to be votes cast and, accordingly, will have no effect on the outcome of the vote on this proposal. Recommendation of the Board of Directors

| The Board of Directors unanimously recommends a vote FOR the election of each of the below Class I Director nominees. |

7

TABLE OF CONTENTS

Nominees For Class I Director (terms to expire at the 2028 Annual Meeting) The current members of the Board of Directors who are also nominees for election to the Board of Directors as Class I Directors are as follows:

| Name               |     | Age |     |    Served as a 
 Director Since |     | Position with P3        |
| Sherif Abdou, M.D. |     |  64 |     |           2017 |     | Vice Chair of the Board |
| Greg Kazarian      |     |  63 |     |           2017 |     | Director                |
| Greg Wasson        |     |  66 |     |           2020 |     | Director                |

The principal occupations and business experience, for at least the past five years, of each Class I Director nominee for election at the 2025 Annual Meeting are as follows: Sherif Abdou, M.D. Sherif Abdou, M.D. is a co-founder of P3 and served as P3’s Chief Executive Officer from 2017 until 2024. He has served on the P3 Health Group Holdings, LLC (“Legacy P3”) Board of Managers since 2017 and as a director of the Company since December 2021